US Federal 2025-2026 Regular Session

US Federal House Bill HB6668

Introduced
 
Introduced
12/11/25  
Refer
12/11/25  

Caption

Clean Water Standards for PFAS Act of 2025

Summary

The Clean Water Standards for PFAS Act of 2025 would direct the Environmental Protection Agency to establish federal water quality criteria and effluent limitations guidelines for measurable PFAS chemicals under the Clean Water Act. The bill sets deadlines for EPA to publish human health water quality criteria within three years and to finalize discharge standards for several industry categories on a phased schedule from 2026 through 2028, including organic chemicals, electroplating, metal finishing, textile mills, landfills, leather tanning, paint formulating, and plastics molding. It also requires EPA to require monitoring of PFAS discharges from those and certain additional sectors, such as pulp and paper, airports, and electrical and electronic components. In addition to setting standards and monitoring requirements, the bill would require EPA to decide by the end of 2026 whether to begin developing standards for certain additional point sources and, if so, to publish those standards by the end of 2028. It also directs EPA to promulgate Method 1633A, a PFAS testing method for aqueous, solid, biosolids, and tissue samples, by January 31, 2026, and to notify congressional committees whenever required publications are made. The bill authorizes appropriations for EPA implementation and for grants to publicly owned treatment works to support pretreatment programs and local PFAS monitoring. The bill would affect federal environmental law by adding specific PFAS-related obligations to the Clean Water Act framework, expanding EPA’s duties to regulate, monitor, and measure PFAS in wastewater and industrial discharges. It would also create a grant program for publicly owned treatment works and authorize substantial funding: $200 million annually for pretreatment grants from fiscal years 2026 through 2030, and $12 million annually for other implementation activities over the same period. Overall sentiment in the available record appears neutral to supportive of stronger PFAS regulation, but there is no committee transcript or vote history provided to show debate or opposition. The bill has been introduced and referred to the Subcommittee on Water Resources and Environment, indicating it is still in the early legislative process. Because no votes or hearing remarks are included, there is no recorded public sentiment in the supplied materials beyond the bill’s regulatory and funding focus. The main points of potential contention are likely to be the scope and timing of EPA mandates, the industries covered, and the cost of compliance and monitoring. Industry sectors subject to new discharge limits and monitoring requirements may oppose the bill’s deadlines or argue that PFAS measurement and treatment are technically difficult or expensive. Supporters would likely emphasize public health protection, cleaner drinking water, and the need for national PFAS standards rather than a patchwork of state or local rules.

Impact

The bill would amend the federal Clean Water Act regulatory framework by requiring EPA to issue PFAS-specific water quality criteria, effluent limitations guidelines, and monitoring requirements for designated industrial categories and discharges to publicly owned treatment works. It would also require EPA to adopt a specific PFAS analytical method and establish a grant program for publicly owned treatment works to address PFAS contamination and local source tracking. The bill authorizes new federal spending for these activities and would likely increase regulatory obligations for affected industries, wastewater utilities, and EPA.

Sentiment

No committee transcript or vote history is provided, so there is no direct record of debate, amendments, or roll-call support/opposition. Based on the text, the bill reflects a pro-regulatory, public-health-oriented approach to PFAS contamination, suggesting likely support from environmental and water-quality advocates. Any opposition would most likely come from regulated industries and possibly wastewater operators concerned about cost, feasibility, and implementation timelines.

Contention

The likely areas of contention are the breadth of PFAS regulation, the short deadlines for EPA action, and the compliance burden on industries and treatment works. Affected sectors such as chemical manufacturing, electroplating, metal finishing, textiles, landfills, leather tanning, paint formulation, plastics molding, airports, and paper mills may object to monitoring and discharge limits. Publicly owned treatment works may support the grant funding but could still raise concerns about the scale of PFAS contamination entering their systems and the resources needed to comply.

Companion Bills

US SB3457

Same As Clean Water Standards for PFAS Act of 2025

Previously Filed As

US SB3457

Clean Water Standards for PFAS Act of 2025

US HB8632

PFAS Cleanup Act

US HB1267

Water Systems PFAS Liability Protection Act

US HB1366

PFAS water safety standards.

US HB1239

PFAS water safety standards.

US SB3460

PFAS Accountability Act of 2025

US HB6626

PFAS Accountability Act of 2025

US SB3101

EPA-PFAS STANDARDS

US SB454

State Water Resources Control Board: PFAS Mitigation Program.

US HF3962

Identification and reporting on priority PFAS required, PFAS management protocol required, and rulemaking required.

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.